The global Desloratadine API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Desloratadine API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Desloratadine API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Desloratadine API include MOREPEN LABORATORIES LTD, SUN PHARMACEUTICAL INDUSTRIES LTD, LUPIN LTD, ORBION PHARMACEUTICALS PRIVATE LTD, GLENMARK LIFE SCIENCES LTD, DR REDDYS LABORATORIES LTD, CADILA PHARMACEUTICALS LTD, MYLAN LABORATORIES LTD and TARO PHARMACEUTICAL INDUSTRIES LTD, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Desloratadine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Desloratadine API.
The Desloratadine API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Desloratadine API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Desloratadine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
MOREPEN LABORATORIES LTD
SUN PHARMACEUTICAL INDUSTRIES LTD
LUPIN LTD
ORBION PHARMACEUTICALS PRIVATE LTD
GLENMARK LIFE SCIENCES LTD
DR REDDYS LABORATORIES LTD
CADILA PHARMACEUTICALS LTD
MYLAN LABORATORIES LTD
TARO PHARMACEUTICAL INDUSTRIES LTD
VASUDHA PHARMA CHEM LTD
HETERO LABS
CIPLA
ROLABO OUTSOURCING
HAINAN POLY PHARMACEUTICAL COMPANY
Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical
Venturepharm Pharmaceuticals锛坔ainan锛�
Zhejiang Huahai Pharmaceutical
Segment by Type
笔耻谤颈迟测鈮�99%
Purity<99%
Segment by Application
Tablet
Oral Solution
Syrup
Capsule
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Desloratadine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Desloratadine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Desloratadine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Desloratadine API Market Overview
1.1 Product Definition
1.2 Desloratadine API Segment by Type
1.2.1 Global Desloratadine API Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 笔耻谤颈迟测鈮�99%
1.2.3 Purity<99%
1.3 Desloratadine API Segment by Application
1.3.1 Global Desloratadine API Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Tablet
1.3.3 Oral Solution
1.3.4 Syrup
1.3.5 Capsule
1.3.6 Others
1.4 Global Market Growth Prospects
1.4.1 Global Desloratadine API Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Desloratadine API Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Desloratadine API Production Estimates and Forecasts (2018-2029)
1.4.4 Global Desloratadine API Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Desloratadine API Production Market Share by Manufacturers (2018-2023)
2.2 Global Desloratadine API Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Desloratadine API, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Desloratadine API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Desloratadine API Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Desloratadine API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Desloratadine API, Product Offered and Application
2.8 Global Key Manufacturers of Desloratadine API, Date of Enter into This Industry
2.9 Desloratadine API Market Competitive Situation and Trends
2.9.1 Desloratadine API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Desloratadine API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Desloratadine API Production by Region
3.1 Global Desloratadine API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Desloratadine API Production Value by Region (2018-2029)
3.2.1 Global Desloratadine API Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Desloratadine API by Region (2024-2029)
3.3 Global Desloratadine API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Desloratadine API Production by Region (2018-2029)
3.4.1 Global Desloratadine API Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Desloratadine API by Region (2024-2029)
3.5 Global Desloratadine API Market Price Analysis by Region (2018-2023)
3.6 Global Desloratadine API Production and Value, Year-over-Year Growth
3.6.1 North America Desloratadine API Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Desloratadine API Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Desloratadine API Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Desloratadine API Production Value Estimates and Forecasts (2018-2029)
4 Desloratadine API Consumption by Region
4.1 Global Desloratadine API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Desloratadine API Consumption by Region (2018-2029)
4.2.1 Global Desloratadine API Consumption by Region (2018-2023)
4.2.2 Global Desloratadine API Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Desloratadine API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Desloratadine API Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Desloratadine API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Desloratadine API Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Desloratadine API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Desloratadine API Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Desloratadine API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Desloratadine API Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Desloratadine API Production by Type (2018-2029)
5.1.1 Global Desloratadine API Production by Type (2018-2023)
5.1.2 Global Desloratadine API Production by Type (2024-2029)
5.1.3 Global Desloratadine API Production Market Share by Type (2018-2029)
5.2 Global Desloratadine API Production Value by Type (2018-2029)
5.2.1 Global Desloratadine API Production Value by Type (2018-2023)
5.2.2 Global Desloratadine API Production Value by Type (2024-2029)
5.2.3 Global Desloratadine API Production Value Market Share by Type (2018-2029)
5.3 Global Desloratadine API Price by Type (2018-2029)
6 Segment by Application
6.1 Global Desloratadine API Production by Application (2018-2029)
6.1.1 Global Desloratadine API Production by Application (2018-2023)
6.1.2 Global Desloratadine API Production by Application (2024-2029)
6.1.3 Global Desloratadine API Production Market Share by Application (2018-2029)
6.2 Global Desloratadine API Production Value by Application (2018-2029)
6.2.1 Global Desloratadine API Production Value by Application (2018-2023)
6.2.2 Global Desloratadine API Production Value by Application (2024-2029)
6.2.3 Global Desloratadine API Production Value Market Share by Application (2018-2029)
6.3 Global Desloratadine API Price by Application (2018-2029)
7 Key Companies Profiled
7.1 MOREPEN LABORATORIES LTD
7.1.1 MOREPEN LABORATORIES LTD Desloratadine API Corporation Information
7.1.2 MOREPEN LABORATORIES LTD Desloratadine API Product Portfolio
7.1.3 MOREPEN LABORATORIES LTD Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.1.4 MOREPEN LABORATORIES LTD Main Business and Markets Served
7.1.5 MOREPEN LABORATORIES LTD Recent Developments/Updates
7.2 SUN PHARMACEUTICAL INDUSTRIES LTD
7.2.1 SUN PHARMACEUTICAL INDUSTRIES LTD Desloratadine API Corporation Information
7.2.2 SUN PHARMACEUTICAL INDUSTRIES LTD Desloratadine API Product Portfolio
7.2.3 SUN PHARMACEUTICAL INDUSTRIES LTD Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.2.4 SUN PHARMACEUTICAL INDUSTRIES LTD Main Business and Markets Served
7.2.5 SUN PHARMACEUTICAL INDUSTRIES LTD Recent Developments/Updates
7.3 LUPIN LTD
7.3.1 LUPIN LTD Desloratadine API Corporation Information
7.3.2 LUPIN LTD Desloratadine API Product Portfolio
7.3.3 LUPIN LTD Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.3.4 LUPIN LTD Main Business and Markets Served
7.3.5 LUPIN LTD Recent Developments/Updates
7.4 ORBION PHARMACEUTICALS PRIVATE LTD
7.4.1 ORBION PHARMACEUTICALS PRIVATE LTD Desloratadine API Corporation Information
7.4.2 ORBION PHARMACEUTICALS PRIVATE LTD Desloratadine API Product Portfolio
7.4.3 ORBION PHARMACEUTICALS PRIVATE LTD Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.4.4 ORBION PHARMACEUTICALS PRIVATE LTD Main Business and Markets Served
7.4.5 ORBION PHARMACEUTICALS PRIVATE LTD Recent Developments/Updates
7.5 GLENMARK LIFE SCIENCES LTD
7.5.1 GLENMARK LIFE SCIENCES LTD Desloratadine API Corporation Information
7.5.2 GLENMARK LIFE SCIENCES LTD Desloratadine API Product Portfolio
7.5.3 GLENMARK LIFE SCIENCES LTD Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.5.4 GLENMARK LIFE SCIENCES LTD Main Business and Markets Served
7.5.5 GLENMARK LIFE SCIENCES LTD Recent Developments/Updates
7.6 DR REDDYS LABORATORIES LTD
7.6.1 DR REDDYS LABORATORIES LTD Desloratadine API Corporation Information
7.6.2 DR REDDYS LABORATORIES LTD Desloratadine API Product Portfolio
7.6.3 DR REDDYS LABORATORIES LTD Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.6.4 DR REDDYS LABORATORIES LTD Main Business and Markets Served
7.6.5 DR REDDYS LABORATORIES LTD Recent Developments/Updates
7.7 CADILA PHARMACEUTICALS LTD
7.7.1 CADILA PHARMACEUTICALS LTD Desloratadine API Corporation Information
7.7.2 CADILA PHARMACEUTICALS LTD Desloratadine API Product Portfolio
7.7.3 CADILA PHARMACEUTICALS LTD Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.7.4 CADILA PHARMACEUTICALS LTD Main Business and Markets Served
7.7.5 CADILA PHARMACEUTICALS LTD Recent Developments/Updates
7.8 MYLAN LABORATORIES LTD
7.8.1 MYLAN LABORATORIES LTD Desloratadine API Corporation Information
7.8.2 MYLAN LABORATORIES LTD Desloratadine API Product Portfolio
7.8.3 MYLAN LABORATORIES LTD Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.8.4 MYLAN LABORATORIES LTD Main Business and Markets Served
7.7.5 MYLAN LABORATORIES LTD Recent Developments/Updates
7.9 TARO PHARMACEUTICAL INDUSTRIES LTD
7.9.1 TARO PHARMACEUTICAL INDUSTRIES LTD Desloratadine API Corporation Information
7.9.2 TARO PHARMACEUTICAL INDUSTRIES LTD Desloratadine API Product Portfolio
7.9.3 TARO PHARMACEUTICAL INDUSTRIES LTD Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.9.4 TARO PHARMACEUTICAL INDUSTRIES LTD Main Business and Markets Served
7.9.5 TARO PHARMACEUTICAL INDUSTRIES LTD Recent Developments/Updates
7.10 VASUDHA PHARMA CHEM LTD
7.10.1 VASUDHA PHARMA CHEM LTD Desloratadine API Corporation Information
7.10.2 VASUDHA PHARMA CHEM LTD Desloratadine API Product Portfolio
7.10.3 VASUDHA PHARMA CHEM LTD Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.10.4 VASUDHA PHARMA CHEM LTD Main Business and Markets Served
7.10.5 VASUDHA PHARMA CHEM LTD Recent Developments/Updates
7.11 HETERO LABS
7.11.1 HETERO LABS Desloratadine API Corporation Information
7.11.2 HETERO LABS Desloratadine API Product Portfolio
7.11.3 HETERO LABS Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.11.4 HETERO LABS Main Business and Markets Served
7.11.5 HETERO LABS Recent Developments/Updates
7.12 CIPLA
7.12.1 CIPLA Desloratadine API Corporation Information
7.12.2 CIPLA Desloratadine API Product Portfolio
7.12.3 CIPLA Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.12.4 CIPLA Main Business and Markets Served
7.12.5 CIPLA Recent Developments/Updates
7.13 ROLABO OUTSOURCING
7.13.1 ROLABO OUTSOURCING Desloratadine API Corporation Information
7.13.2 ROLABO OUTSOURCING Desloratadine API Product Portfolio
7.13.3 ROLABO OUTSOURCING Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.13.4 ROLABO OUTSOURCING Main Business and Markets Served
7.13.5 ROLABO OUTSOURCING Recent Developments/Updates
7.14 HAINAN POLY PHARMACEUTICAL COMPANY
7.14.1 HAINAN POLY PHARMACEUTICAL COMPANY Desloratadine API Corporation Information
7.14.2 HAINAN POLY PHARMACEUTICAL COMPANY Desloratadine API Product Portfolio
7.14.3 HAINAN POLY PHARMACEUTICAL COMPANY Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.14.4 HAINAN POLY PHARMACEUTICAL COMPANY Main Business and Markets Served
7.14.5 HAINAN POLY PHARMACEUTICAL COMPANY Recent Developments/Updates
7.15 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical
7.15.1 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Desloratadine API Corporation Information
7.15.2 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Desloratadine API Product Portfolio
7.15.3 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.15.4 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Main Business and Markets Served
7.15.5 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Recent Developments/Updates
7.16 Venturepharm Pharmaceuticals锛坔ainan锛�
7.16.1 Venturepharm Pharmaceuticals锛坔ainan锛� Desloratadine API Corporation Information
7.16.2 Venturepharm Pharmaceuticals锛坔ainan锛� Desloratadine API Product Portfolio
7.16.3 Venturepharm Pharmaceuticals锛坔ainan锛� Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.16.4 Venturepharm Pharmaceuticals锛坔ainan锛� Main Business and Markets Served
7.16.5 Venturepharm Pharmaceuticals锛坔ainan锛� Recent Developments/Updates
7.17 Zhejiang Huahai Pharmaceutical
7.17.1 Zhejiang Huahai Pharmaceutical Desloratadine API Corporation Information
7.17.2 Zhejiang Huahai Pharmaceutical Desloratadine API Product Portfolio
7.17.3 Zhejiang Huahai Pharmaceutical Desloratadine API Production, Value, Price and Gross Margin (2018-2023)
7.17.4 Zhejiang Huahai Pharmaceutical Main Business and Markets Served
7.17.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Desloratadine API Industry Chain Analysis
8.2 Desloratadine API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Desloratadine API Production Mode & Process
8.4 Desloratadine API Sales and Marketing
8.4.1 Desloratadine API Sales Channels
8.4.2 Desloratadine API Distributors
8.5 Desloratadine API Customers
9 Desloratadine API Market Dynamics
9.1 Desloratadine API Industry Trends
9.2 Desloratadine API Market Drivers
9.3 Desloratadine API Market Challenges
9.4 Desloratadine API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
MOREPEN LABORATORIES LTD
SUN PHARMACEUTICAL INDUSTRIES LTD
LUPIN LTD
ORBION PHARMACEUTICALS PRIVATE LTD
GLENMARK LIFE SCIENCES LTD
DR REDDYS LABORATORIES LTD
CADILA PHARMACEUTICALS LTD
MYLAN LABORATORIES LTD
TARO PHARMACEUTICAL INDUSTRIES LTD
VASUDHA PHARMA CHEM LTD
HETERO LABS
CIPLA
ROLABO OUTSOURCING
HAINAN POLY PHARMACEUTICAL COMPANY
Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical
Venturepharm Pharmaceuticals锛坔ainan锛�
Zhejiang Huahai Pharmaceutical
听
听
*If Applicable.
